Loading…
avatar for Tarek Hammad

Tarek Hammad

Sanofi Genzyme
Therapeutic Area Strategy Lead, Global Pharmacovigilance
Dr. Hammad joined Sanofi-Genzyme, in 2019, as a Therapeutic Area Strategy Lead in the Global Pharmacovigilance group. Prior to this, he served as the Head of Signal Detection and Benefit-Risk Assessment in Merck KGaA/EMD Serono. Previously, he was an Executive Director of Pharmacoepidemiology in Merck. Dr. Hammad has had a distinguished career with the US FDA, the latest being the Deputy Director, Division of Epidemiology, CDER. He is nationally and internationally recognized as drug safety and benefit-risk expert. He has authored many peer-reviewed publications and made many presentations in various scientific settings. For more information, check his website www.DrTarekHammad.com.